Clinical Trial Update: ZIAGEN® Post-marketing Surveillance

View source ↗

Summary

This document reports the completion of a post-marketing surveillance study for ZIAGEN (abacavir) sponsored by ViiV Healthcare.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ziagen (Abacavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus I | Status: COMPLETED